Literature DB >> 10556443

Laparoscopic splenectomy for idiopathic thrombocytopenic purpura (ITP). A five-year experience.

C J Stanton1.   

Abstract

BACKGROUND: Laparoscopic splenectomy (LS) has rapidly become the preferred surgical treatment for idiopathic thrombocytopenic purpura (ITP), but its long-term efficacy for this disorder is unproved. This report documents the author's 5-year experience with, and long-term follow-up of, LS for ITP.
METHODS: Between September 1992 and September 1997, 30 patients with clinical ITP and intractable thrombocytopenia were referred as surgical candidates. Two of them (7%) were converted to open, and the other 28 underwent successful LS. The operative approach evolved from a supine lithotomy to right lateral decubitus position, and the harmonic scalpel became the primary dissection tool in the later part of the study.
RESULTS: The 28 successful LS patients constituted the study group. Accessory spleens were identified and resected in six patients (21%). Surgical times and blood loss averaged 2.4 h and 170 cc, respectively. The typical hospital stay was 2 days. Initial reversal of thrombocytopenia and ultimate cessation of oral steroids was achieved in 25 of 28 patients (89%). There were no deaths, but two patients had major complications (bleeding and pneumonia). All but two patients experienced a return to full activity and/or employment by 3 weeks post-LS. In the three cases that failed LS, none had residual splenic tissue on subsequent radionuclide scan. Long-term follow-up (2-60 months) was obtained in 22 of 28 patients (79%). The only death (at 13 months) resulted from oncologic disease. Twenty-one patients had lasting clinical remission of ITP. A positive preoperative response to oral steroids was the best predictor of success.
CONCLUSIONS: This 5-year experience with LS supports its use for the surgical treatment of ITP. The procedure is safe and efficacious, resulting in brief hospitalization, minimal recovery time, and excellent long-term results.

Entities:  

Mesh:

Year:  1999        PMID: 10556443     DOI: 10.1007/s004649901178

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  6 in total

1.  Determination of intact splenic weight based on morcellated weight.

Authors:  R M Walsh; B Chand; J Brodsky; B T Heniford
Journal:  Surg Endosc       Date:  2003-05-20       Impact factor: 4.584

2.  Predictive factors for successful laparoscopic splenectomy in immune thrombocytopenic purpura: study of clinical and laboratory data.

Authors:  C Balagué; S Vela; E M Targarona; I J Gich; E Muñiz; A D'Ambra; A Pey; V Monllau; E Ascaso; C Martinez; J Garriga; M Trias
Journal:  Surg Endosc       Date:  2006-07-24       Impact factor: 4.584

3.  Laparoscopic splenectomy for hematological diseases.

Authors:  P Torelli; D Cavaliere; M Casaccia; F Panaro; P Grondona; E Rossi; G Santini; M Truini; M Gobbi; A Bacigalupo; U Valente
Journal:  Surg Endosc       Date:  2002-02-28       Impact factor: 4.584

4.  Prognostic factors of response to laparoscopic splenectomy in patients with idiopathic thrombocytopenic purpura.

Authors:  Hyuk-Chan Kwon; Chang-Hoon Moon; Young-Rak Cho; Min-Chan Kim; Kyeong-Hee Kim; Jin-Yeong Han; Young-Ho Lee; Sung-Yong Oh; Sung-Hyun Kim; Jae-Seok Kim; Hyo-Jin Kim
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

5.  Long-term outcome after laparoscopic splenectomy related to hematologic diagnosis.

Authors:  C Balagué; E M Targarona; G Cerdán; J Novell; O Montero; G Bendahan; A García; A Pey; S Vela; M Diaz; M Trías
Journal:  Surg Endosc       Date:  2004-06-23       Impact factor: 4.584

Review 6.  Pediatric laparoscopic splenectomy: benefits of the anterior approach.

Authors:  P de Lagausie; A Bonnard; M Benkerrou; P Rorlich; A de Ribier; Y Aigrain
Journal:  Surg Endosc       Date:  2003-11-21       Impact factor: 4.584

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.